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Clinical case report
Mr  R.,  52  years  old,  presented  to  the  breast  unit,  reporting  an  approximately  one-year  his-
tory  of  an  increase  in  size  to  his  left  nipple.  On  clinical  examination,  the  left  breast  areola
was  indurated  and  reddish-brown  in  colour  (Fig.  1).  No  lymphadenopathy  was  noted.  He
did  not  present,  and  had  never  presented,  any  other  cutaneous  lesion  suggestive  of  ery-
thema  migrans.  He  has  no  medical  history  noted  works  in  construction,  and  since  he  enjoys
hunting,  he  did  recall  being  bitten  by  ticks  on  a  number  of  occasions  in  the  past.  A  mam-
mography  revealed  thickening  of  the  skin  of  the  left  areola  and  nipple,  while  sonography
demonstrated  a  hypoechoic  left  retroareolar  image,  6  mm  in  size  (Figs.  2  and  3).  A  deep
nipple  biopsy  revealed  a B-cell  pseudolymphoma-type  lymphoid  inﬁltrate  (Figs.  4a  and  b),
while  cytopathology  of  the  retroareolar  area  only  found  ﬁbrous  and  adipose  tissue.  Sero-
logic  testing  for  Lyme  disease  (LD)  was  positive  (IgG+,  IgM—),  and  was  conﬁrmed  by  Western
Blot.  In  view  of  the  sonography  ﬁndings,  the  retroareolar  opacity  was  excised.  The  result-
ing  histology  was  suggestive  of  a  lipoma.  Empirical  antibiotic  therapy  was  started  with  a
21-day  course  of  oral  doxycycline  (100  mg  twice  a  day),  which  caused  the  initial  lesion  to
improve  and  then  resolve,  conﬁrming  the  diagnosis  of  Lyme  disease.
Abbreviations: LD, Lyme Disease; BL, Borrelial Lymphocytoma; EM, Erythema migrans.
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Figure 1. Clinical features: reddish-brown oedematous indura-
tion forming a plaque to the left areola and nipple, slight
inﬁltration, no deep internal adhesion, tender on palpation, and
Figure 2. Features of borrelial lymphocytoma on mammography:
right (a) and left lateral view (b) demonstrating cutaneous thicken-
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if  the  result  is  positive,  can  be  conﬁrmed  by  a  speciﬁcits size appears to have increased compared to the contralateral
side. No regional lymphadenopathy.
Discussion
LD  is  a  zoonosis  that  is  transmitted  to  humans  by  tick  bites
and  is  caused  by  an  infection  with  a  bacterium  of  the  Borre-
lia  genus.  Borrelial  lymphocytoma  (BL)  is  a  rare  cutaneous
manifestation  of  LD  that  occurs  in  the  second  stage,  sev-
eral  weeks  or  months  after  the  bite.  The  patient  does  not
usually  show  any  other  general  signs  [1].  It  occurs  in  2%  of
adults  and  7%  of  chidren  affected  with  borreliosis  [2]  and  is
mainly  found  among  European  cases.  In  30  to  50%  of  cases
this  is  the  sign  that  reveals  the  disease,  because  erythema
migrans  (EM)  did  not  present  or  was  not  noticed.  In  contrast
to  EM,  it  usually  develops  away  from  the  site  of  the  bite.  The
combination  of  lymphocytoma  and  EM  is  pathognomonic  for
Lyme  disease.  Clinically  there  is  a  ﬁrm,  painless  nodule  or
plaque  that  may  be  pink,  red,  reddish-brown,  deep  purple
or  blue,  varying  in  size  from  1  to  5  cm  and  it  typically  devel-
ops  on  the  ear  (helix  or  lobe)  in  children  and  the  nipple
or  areola  in  adults.  It  also  commonly  develops  on  the  torso,
Figure 3. Sonogram features; a: cutaneous thickening of the areola 
white arrow); b: hypoechoic and non-homogenous retroareolar image, 6 m
(broad white arrow).
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tng of the left areola and nipple with no associated gynecomastia,
icro-calciﬁcations or mass within the breast.
ace  or  scrotum.  Regional  lymphadenopathy  is  almost  always
resent.  BL  can  be  diagnosed  clinically  because  its  location
s  typical  and  the  history  of  the  illness  is  highly  sugges-
ive.  Nonetheless,  conﬁrmation  through  laboratory  testing
s  recommended.  The  main  clinical  differential  diagnoses
re  primary  or  secondary  cutaneous  lymphoma,  sarcoido-
is,  nodular  gynecomastia,  urticaria-like  follicular  mucinosis
nd  the  other  possible  causes  of  pseudolymphomas  (medica-
ions,  tattoos  etc.).  Serological  testing  is  positive  in  between
5  and  78.7%  of  cases  [3].  The  recommendation  is  to  use
 sensitive  screening  method,  starting  with  ELISA,  which,and nipple shown as a hypodense, well-circumscribed area (thin
m in diameter, with regular margins, located 8 mm below the skin
mmunostaining  technique  [4].  The  later  the  stage  at  which
erological  testing  is  carried  out,  the  more  likely  a  posi-
ive  result  becomes  [5].  Unless  the  patient  is  both  in  an
106  L.  Foessel  et  al.
Figure 4. Histology ﬁndings for the cutaneous lesion: HE stain; a × 4; b × 10; c × 40. There is a dense, nodular inﬂammatory inﬁltrate in
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ohe superﬁcial and mid-dermis (b: thin black arrow) consisting main
acrophages (c: black arrows with broad heads).
ndemic  area  and  presents  the  typical  earlobe  localisation,
istological  conﬁrmation  is  required  so  that  a  cutaneous
ymphoma  is  not  misdiagnosed  [3].  Pathological  analysis
eveal  a  dense,  polyclonal  lymphocytic  inﬁltrate  in  the  der-
is  (Fig  4b),  made  up  mainly  of  B-lymphocytes  in  germinal
entres,  together  with  some  tingible  body  macrophages
Fig.  4c).  Antibody  labelling  shows  mainly  B-lymphocytes
CD20)  (Fig.  5a),  a  raised  proliferative  index  in  clear  ger-
inal  centres  (Ki-67)  (Fig.  5b),  a  well-organised  dendritic
etwork  (CD21)  and  cells  are  negative  for  Bcl-2  [3,6]. These
ndicators  of  a  benign  lesion,  especially  the  polyclonal
ature  of  the  proliferating  cells,  allows  BL  to  be  differ-
ntiated  from  a  malignant  pathology.  Borrelia  can  also  be
o
o
r
wsmall lymphocytes, plasma cells and large numbers of tingible body
onﬁrmed  by  gene  ampliﬁcation  (PCR)  or  cultures,  but  these
emain  the  preserve  of  specialist  laboratories  [7,8]. Sponta-
eous  evolution  can  result  in  recurrence  or  involution;  with
reatment,  the  median  length  of  the  disease  course  is  three
o  four  weeks;  treatment  fails  in  12.9%  of  cases  [3].  First-
ine  curative  treatment  for  lymphocytoma  consists  of  a  14
o  21-day  course  of  antibiotic  therapy  with  oral  amoxicillin
500  mg  3×/day  for  adults,  50  mg/kg/day  for  children)  or
ral  doxycycline  (200  mg/day).  It  appears  that  irrespective
f  the  treatment  chosen,  the  duration  of  remission  depends
n  how  early  the  diagnosis  is  made.  Sometimes,  it  is  only  a
esponse  to  treatment  that  belatedly  proves  that  Borrelia
as  the  cause.
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[Figure 5. Immunophenotyping: the inﬁltrate consists mainly of
predominantly feature at the peripheries of the lymphoid nodules.
germinal centres (b).
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